Pfizer says Pandemic could Extend to 2024
Pfizer Inc forecasted that the COVID-19 pandemic would not be behind us until at least 2024 and said a lower-dose version of its vaccine for 2- to 4-year-olds generated a weaker immune response than expected, potentially delaying authorization. Pfizer’s Chief Scientific Officer said in a presentat
BioNTech sees up to EUR 17 B in Vaccine Revenue
Germany’s BioNTech SE said the COVID-19 vaccine it is developing with Pfizer will likely generate up to 17 billion euros ($19.6 billion) in revenues this year, as booster shots take hold and use in children increases.